The Alliance For Clinical Trials

1794 Words8 Pages
The Alliance for Clinical Trials in Oncology is a collaborative effort that is committed to developing and conducting clinical trials to reduce the impact of cancer in patients from all over the world. In recent years this group was formed by three different cooperative groups creating a strategic alliance by combining forces to provide the best services for customers. The customer base in this industry is patients diagnosed with cancer who are seeking cutting edge and experimental treatment options. There are over 10,000 cancer specialists that collaborate in this mission to discover, validate and disseminate effective strategies for the prevention and treatment of cancer. It is important to conduct these clinical trials to save the…show more content…
Another way that clinical trials are sponsored within the Alliance for Clinical Trials in Oncology is through pharmaceutical companies such as Novartis, Celegene, Exelixis, etc. This creates an entirely different route for value analysis, although this is done on the pharmaceutical company side as they are sponsoring the Alliance to conduct the trials. The pharmaceutical companies tend to ask for more in-depth cleaning of the data so priorities can differ from that of the Alliance sponsored trials. I work on trials that are Alliance funded but I have spent most of my time within Mayo Clinic’s Cancer Center working on industry sponsored trials. I recently worked on a Novartis funded trial that developed a drug undergoing FDA approval to treat patients diagnosed with Acute Myeloid Leukemia.

Supply Chain The first step in developing a clinical trial is the doctor’s idea for a new treatment. Once it is determined to be scientifically viable and after several committee meetings, a protocol is developed. A protocol is the official playbook or system of rules governing each step of treatment or intervention from beginning to end. The protocol also explains the history of the disease and the treatment drug being used in the trial. Also discussed are the primary endpoint and all endpoints thereafter and lays out the statistical considerations before the trial begins. This is a very intricate part of creating clinical trials
Get Access